Jason J McDougall Selected Research

mu Opioid Receptors (mu Opioid Receptor)

10/2005	Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.
4/2004	Loss of vasomotor responsiveness to the mu-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason J McDougall Research Topics

Disease

39	Pain (Aches) 01/2024 - 07/2003
31	Inflammation (Inflammations) 07/2022 - 01/2004
21	Arthralgia (Joint Pain) 10/2022 - 10/2005
20	Arthritis (Polyarthritis) 10/2022 - 07/2003
14	Osteoarthritis 10/2022 - 07/2006
14	Hyperalgesia 01/2021 - 07/2006
6	Neuralgia (Stump Neuralgia) 10/2022 - 08/2017
5	Chronic Pain 01/2024 - 04/2011
5	Synovitis 01/2021 - 06/2013
4	Demyelinating Diseases (Demyelinating Disease) 10/2022 - 01/2017
4	Neurogenic Inflammation 10/2020 - 01/2016
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2017
2	Hypersensitivity (Allergy) 01/2020 - 01/2016
2	Edema (Dropsy) 08/2017 - 03/2009
2	Infections 02/2011 - 01/2011
2	Cicatrix (Scar) 07/2008 - 09/2006
1	Neuroinflammatory Diseases 10/2020
1	Erythema 01/2016
1	Experimental Arthritis 01/2016
1	Dermatitis 01/2016
1	Contact Dermatitis (Eczema, Contact) 01/2016
1	Gout 01/2016

Drug/Important Bio-Agent (IBA)

10	Analgesics (Analgesic Drugs)IBA 01/2024 - 10/2005
8	Peptide Hydrolases (Proteases)FDA Link 08/2021 - 01/2010
8	CarrageenanIBA 01/2021 - 01/2004
8	NeuropeptidesIBA 10/2020 - 01/2004
7	Proteinase-Activated ReceptorsIBA 08/2021 - 01/2006
7	KaolinIBA 01/2021 - 01/2004
7	EndocannabinoidsIBA 10/2020 - 05/2011
6	CannabinoidsIBA 10/2020 - 01/2008
5	SodiumIBA 10/2022 - 07/2006
5	Peptides (Polypeptides)IBA 10/2022 - 05/2006
4	Voltage-Gated Sodium ChannelsIBA 01/2024 - 01/2012
4	Ion Channels (Ion Channel)IBA 10/2022 - 11/2005
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022 - 08/2011
4	Serine Proteases (Serine Protease)IBA 08/2021 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
3	Sodium Channels (Sodium Channel)IBA 01/2024 - 01/2012
3	lysophosphatidic acidIBA 10/2022 - 01/2019
3	EnzymesIBA 08/2021 - 05/2011
3	Capsaicin (Zostrix)FDA Link 01/2021 - 09/2005
3	Iodoacetic AcidIBA 01/2021 - 11/2009
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021 - 02/2016
3	CytokinesIBA 01/2018 - 12/2012
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2017 - 05/2011
3	Opioid Analgesics (Opioids)IBA 04/2011 - 10/2005
3	endomorphin 1IBA 10/2005 - 01/2004
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 10/2022 - 01/2021
2	CannabidiolIBA 07/2022 - 12/2017
2	A 803467IBA 01/2019 - 01/2012
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2017 - 05/2011
2	Type 3 Galanin ReceptorIBA 01/2016 - 01/2016
2	GalaninIBA 01/2016 - 01/2016
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2006 - 05/2005
2	LigandsIBA 01/2006 - 01/2004
2	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2005 - 04/2004
1	Monoterpenes (Monoterpenoids)IBA 07/2022
1	myrceneIBA 07/2022
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	N- (N- (3- carboxyoxirane- 2- carbonyl)leucyl)isoamylamineIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	QX-314IBA 01/2021
1	calpain inhibitorsIBA 01/2021
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	CalpainIBA 01/2021
1	FlagellinIBA 01/2021
1	protease-activated receptor 4IBA 01/2021
1	Monoacylglycerol LipasesIBA 01/2020
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	iodopravadoline (AM 630)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	Drinking WaterIBA 01/2018
1	Medical MarijuanaIBA 01/2018
1	Probenecid (Benemid)FDA LinkGeneric 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	sivelestatIBA 08/2017
1	Tryptases (Tryptase)IBA 09/2016
1	TachykininsIBA 09/2016
1	Neurokinin AIBA 09/2016
1	Tachykinin Receptors (Tachykinin Receptor)IBA 09/2016
1	Substance PIBA 09/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	2- (5- methylhexahydropyrrolo(3,4- c)pyrrol- 2- yl)xanthen- 9- oneIBA 02/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2016
1	methyllycaconitineIBA 02/2016
1	U 0126 (UO 126)IBA 02/2016
1	des-Arg(9)- bradykininIBA 01/2016
1	AllergensIBA 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016
1	Lysine Carboxypeptidase (Carboxypeptidase N)IBA 01/2016
1	InterleukinsIBA 01/2016

Therapy/Procedure

16	Intra-Articular Injections 10/2022 - 01/2004
7	Therapeutics 01/2024 - 01/2011
2	Lasers (Laser) 07/2022 - 01/2021
1	Injections 01/2021
1	Spinal Injections 11/2020
1	Drug Therapy (Chemotherapy) 09/2017